LIXTE BIOTECHNOLOGY HLDGS IN COM

LIXTE BIOTECHNOLOGY HLDGS IN COM is a security (CUSIP 539319301) tracked across SEC portfolio filings. 18 institutional managers reported $2.4M on Form 13F as of 2026-06-30; 1 registered fund positions totaling $152K via N-PORT as of 2026-03-31.

Summary

Top institutional holders (Form 13F)

Showing 15 of 18 managers by value.

ManagerLocationValueShares
SCOTIA CAPITAL INC.TORONTO, A6$869K283,162
VANGUARD GROUP INCValley Forge, PA$295K74,944
RENAISSANCE TECHNOLOGIES LLCNEW YORK, NY$286K93,000
Federation des caisses Desjardins du QuebecLEVIS, A8$198K64,487
GEODE CAPITAL MANAGEMENT, LLCBOSTON, MA$181K58,852
CITADEL ADVISORS LLCMIAMI, FL$174K56,557
Atlas Legacy Advisors, LLCLOS ANGELES, CA$102K13,771
AXXCESS WEALTH MANAGEMENT, LLCCARLSBAD, CA$102K13,771
Ethos Financial Group, LLCKING OF PRUSSIA, PA$76K24,808
XTX Topco LtdLONDON, X0$72K23,446
STATE STREET CORPBOSTON, MA$53K17,396
Tower Research Capital LLC (TRC)NEW YORK, NY$3K973
SBI Securities Co., Ltd.TOKYO, M0$1K190
FNY Investment Advisers, LLCNEW YORK, NY$33044,566
CLEAR STREET LLCNEW YORK, NY$91100

Top fund holders (N-PORT)

FundRegistrantValue% of fund
VANGUARD EXTENDED MARKET INDEX FUNDVANGUARD INDEX FUNDS$152K0.02%

More